According to Aspen Pharmacare's latest financial reports the company's current earnings are ยฃ2.47 Billion. In 2024 the company made an earning of ยฃ0.24 Billion a decrease over its 2023 earnings that were of ยฃ0.27 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 | ยฃ0.24 B | -9.41% |
2023 | ยฃ0.27 B | -30.33% |
2022 | ยฃ0.38 B | 20.18% |
2021 | ยฃ0.32 B | 71.28% |
2020 | ยฃ0.18 B | 45.91% |
2019 | ยฃ0.12 B | -66.03% |
2018 | ยฃ0.38 B | 2.18% |
2017 | ยฃ0.37 B | 16.58% |
2016 | ยฃ0.31 B | -22.16% |
2015 | ยฃ0.40 B | -11.62% |
2014 | ยฃ0.46 B | 32.23% |
2013 | ยฃ0.35 B | 7.54% |
2012 | ยฃ0.32 B | 4.55% |
2011 | ยฃ0.31 B | 43.51% |
2010 | ยฃ0.21 B | 28% |
2009 | ยฃ0.16 B | 46.12% |
2008 | ยฃ0.11 B | 3.56% |
2007 | ยฃ0.11 B | 21.01% |
2006 | ยฃ92.76 M | 102.69% |
2005 | ยฃ45.76 M | -31.39% |
2004 | ยฃ66.7 M | 40.76% |
2003 | ยฃ47.38 M |